+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sterility Indicators Market By Type, By Sterilization Process, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 312 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713141
The global sterility indicators market was valued at $879.3 million in 2021, and is projected to reach $2,599.3 million by 2031, registering a CAGR of 11.5% from 2022 to 2031. Sterility indicators is a medical device, which is used for testing presence of microorganisms. It confirms the products are free from the presence of viable micro-organism. It is an important device used in sterilization procedure of medical device and preparation of drugs. Sterility indicators are the indicators that are used to check the quality of sterilization and monitoring of the sterilization process. It may be also required to check whether microbial growth occurs or not in terms of sterilization quality. Sterilization indicators are instruments that support load monitoring, regular monitoring, and certification of steam sterilization processes. This instrument can demonstrate whether the circumstances in steam autoclaves are enough to achieve a particular stage of microbial inactivation. It is regarded as a crucial tool for testing the sterilization quality and preventing microbiological development in pharmaceutical preparations and medical devices.

The sterility indicators market is driven by increase in R&D activities by pharmaceutical industry, high prevalence of chronic diseases such as cancer, diabetes, arthritis, and cancer, and rising demand for medicines and medical devices. Sterility indicators are used in research centers and pharmaceutical companies to check sterility of the medicine and medical device for effective results. Thus, rise in the number of chronic diseases cause increase in demand for medicines and medical device. Therefore, this factor drives the demand for sterility indicators in pharmaceutical company and drives the growth of the market. For instance, according to World Health Organization (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed globally. Moreover, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults in the age group of 20-79 suffered from diabetes over the globe. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

In addition, rise in hospital acquired infection fuels the demand for sterility indicators, which further is anticipated to boost the growth of the sterility indicators market. Growing efforts to reduce hospital acquired infections (HAIs) or nosocomial infections is one of the high impacting factors for the market growth. The concept of hospital sterile processing unit is being adopted by developing countries, such as India, China, and Middle East countries. Therefore, rise in the number of sterilization process in hospital surge the growth of the sterility indicators market. Moreover, rise in use of E-beam sterilization and increase in awareness of environmental & personal hygiene due to COVID-19 fuel the growth of the market.

In addition, rise in the number of key players who manufacture sterility indicators, increase in the product launch and product approval for sterility indicators, and rise in expenditure by government to develop healthcare infrastructure are anticipated to fuel the growth of the sterility indicators market. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. healthcare spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in UK accounted for 12.8% of the gross domestic product (GDP) in 2020, as compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and medicine used at public health centers, such as hospitals. On the other hand, sterility indicator equipment flaws like the inability to identify operational issues like overloading the sterilizer, challenging package configuration in the load, improper sterilization equipment, noncompliance with sterilization standards, high device costs, and chemical exposure hamper the growth of the sterility indicators market.

The sterility indicators market is segmented on the basis of type, sterilization process, end user, and region. By type, the market is divided into chemical indicators and biological indicators. The biological indicators is further bifurcated into self-contained vials, spore strips, and others. On the basis sterilization process, the market is segmented into steam, ethylene oxide, dry heat, and others. Others includes hydrogen peroxide and formaldehyde. On the basis of end user, the market is segmented into hospitals, pharmaceutical companies and medical device companies, and clinical laboratories/research centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global sterility indicators market include, 3M Company, Anderson Products, Inc., Fortive Corporation, Cardinal, Crosstex International Inc., Getinge AB, gke-GmbH, Hu-Friedy Mfg. Co., LLC, Matachana Group, Mesa Labs, Inc., MMM Group, Nelson Laboratories, LLC, NOXILIZER INC, Propper Manufacturing Co., Inc., and STERIS plc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the sterility indicator market analysis from 2021 to 2031 to identify the prevailing sterility indicator market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the sterility indicator market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global sterility indicator market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Biological Indicators
  • Type
  • Self contained Vials
  • Spore Strips
  • Others
  • Chemical Indicators

By Sterilization Process

  • Steam
  • Ethylene Oxide
  • Dry Heat
  • Others

By End User

  • Hospitals
  • Pharmaceutical Companies and Medical device Companies
  • Clinical laboratories and Research Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • 3M
  • Anderson Products, Inc.
  • Fortive Corporation
  • Cardinal Health Inc.
  • Crosstex International, Inc
  • Getinge AB
  • gke GmbH
  • Hu Friedy Mfg. Co., LLC
  • Matachana Group
  • Mesa Labs, Inc.
  • MMM GROUP
  • Nelson Laboratories, LLC
  • NOXILIZER INC
  • Propper Manufacturing Co., Inc.
  • Sigma Aldrich
  • STERIS plc
  • STRYKER CORPORATION
Frequently Asked Questions about the Global Sterility Indicators Market

What is the estimated value of the Global Sterility Indicators Market?

The Global Sterility Indicators Market was estimated to be valued at $879.3 million in 2021.

What is the growth rate of the Global Sterility Indicators Market?

The growth rate of the Global Sterility Indicators Market is 11.4%, with an estimated value of $2599.3 million by 2031.

What is the forecasted size of the Global Sterility Indicators Market?

The Global Sterility Indicators Market is estimated to be worth $2599.3 million by 2031.

Who are the key companies in the Global Sterility Indicators Market?

Key companies in the Global Sterility Indicators Market include 3M, Anderson Products, Inc., Fortive Corporation, Cardinal Health Inc., Crosstex International, Inc, Getinge AB, gke GmbH, Hu Friedy Mfg. Co., LLC and Mesa Labs, Inc..

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: STERILITY INDICATORS MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Biological Indicators
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Biological Indicators Sterility Indicators Market by Type
4.2.4.1 Self contained Vials Market size and forecast, by region
4.2.4.2 Spore Strips Market size and forecast, by region
4.2.4.3 Others Market size and forecast, by region
4.3 Chemical Indicators
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country

CHAPTER 5: STERILITY INDICATORS MARKET, BY STERILIZATION PROCESS
5.1 Overview
5.1.1 Market size and forecast
5.2 Steam
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ethylene Oxide
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Dry Heat
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country

CHAPTER 6: STERILITY INDICATORS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Pharmaceutical Companies and Medical device Companies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Clinical laboratories and Research Centers
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: STERILITY INDICATORS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.2.1 North America Biological Indicators Sterility Indicators Market by Type
7.2.3 North America Market size and forecast, by Sterilization Process
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Sterilization Process
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Sterilization Process
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Sterilization Process
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.2.1 Europe Biological Indicators Sterility Indicators Market by Type
7.3.3 Europe Market size and forecast, by Sterilization Process
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Sterilization Process
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Sterilization Process
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Sterilization Process
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Sterilization Process
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Sterilization Process
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Sterilization Process
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.2.1 Asia-Pacific Biological Indicators Sterility Indicators Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Sterilization Process
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Sterilization Process
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Sterilization Process
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Sterilization Process
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Sterilization Process
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Sterilization Process
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Sterilization Process
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.2.1 LAMEA Biological Indicators Sterility Indicators Market by Type
7.5.3 LAMEA Market size and forecast, by Sterilization Process
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Sterilization Process
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Sterilization Process
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Sterilization Process
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Sterilization Process
7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 3M
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Anderson Products, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Fortive Corporation
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cardinal Health Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Crosstex International, Inc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Getinge AB
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 gke GmbH
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Hu Friedy Mfg. Co., LLC
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Matachana Group
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Mesa Labs, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 MMM GROUP
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Nelson Laboratories, LLC
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 NOXILIZER INC
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Propper Manufacturing Co., Inc.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Sigma Aldrich
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 STERIS plc
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 STRYKER CORPORATION
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments

List of Tables
Table 1. Global Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 2. Sterility Indicators Market, for Biological Indicators, by Region, 2021-2031 ($Million)
Table 3. Sterility Indicators Market for Biological Indicators, by Country, 2021-2031 ($Million)
Table 4. Global Biological Indicators Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 5. Sterility Indicators Market, for Self Contained Vials, by Region, 2021-2031 ($Million)
Table 6. Sterility Indicators Market, for Spore Strips, by Region, 2021-2031 ($Million)
Table 7. Sterility Indicators Market, for Others, by Region, 2021-2031 ($Million)
Table 8. Sterility Indicators Market, for Chemical Indicators, by Region, 2021-2031 ($Million)
Table 9. Sterility Indicators Market for Chemical Indicators, by Country, 2021-2031 ($Million)
Table 10. Global Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 11. Sterility Indicators Market, for Steam, by Region, 2021-2031 ($Million)
Table 12. Sterility Indicators Market for Steam, by Country, 2021-2031 ($Million)
Table 13. Sterility Indicators Market, for Ethylene Oxide, by Region, 2021-2031 ($Million)
Table 14. Sterility Indicators Market for Ethylene Oxide, by Country, 2021-2031 ($Million)
Table 15. Sterility Indicators Market, for Dry Heat, by Region, 2021-2031 ($Million)
Table 16. Sterility Indicators Market for Dry Heat, by Country, 2021-2031 ($Million)
Table 17. Sterility Indicators Market, for Others, by Region, 2021-2031 ($Million)
Table 18. Sterility Indicators Market for Others, by Country, 2021-2031 ($Million)
Table 19. Global Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 20. Sterility Indicators Market, for Hospitals, by Region, 2021-2031 ($Million)
Table 21. Sterility Indicators Market for Hospitals, by Country, 2021-2031 ($Million)
Table 22. Sterility Indicators Market, for Pharmaceutical Companies and Medical Device Companies, by Region, 2021-2031 ($Million)
Table 23. Sterility Indicators Market for Pharmaceutical Companies and Medical Device Companies, by Country, 2021-2031 ($Million)
Table 24. Sterility Indicators Market, for Clinical Laboratories and Research Centers, by Region, 2021-2031 ($Million)
Table 25. Sterility Indicators Market for Clinical Laboratories and Research Centers, by Country, 2021-2031 ($Million)
Table 26. Sterility Indicators Market, by Region, 2021-2031 ($Million)
Table 27. North America Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 28. North America Biological Indicators Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 29. North America Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 30. North America Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 31. North America Sterility Indicators Market, by Country, 2021-2031 ($Million)
Table 32. U.S. Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 33. U.S. Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 34. U.S. Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 35. Canada Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 36. Canada Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 37. Canada Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 38. Mexico Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 39. Mexico Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 40. Mexico Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 41. Europe Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 42. Europe Biological Indicators Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 43. Europe Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 44. Europe Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 45. Europe Sterility Indicators Market, by Country, 2021-2031 ($Million)
Table 46. Germany Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 47. Germany Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 48. Germany Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 49. France Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 50. France Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 51. France Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 52. U.S.erility Indicators Market, by Type, 2021-2031 ($Million)
Table 53. U.S.erility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 54. U.S.erility Indicators Market, by End-user, 2021-2031 ($Million)
Table 55. Italy Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 56. Italy Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 57. Italy Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 58. Spain Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 59. Spain Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 60. Spain Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 61. Rest of Europe Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 62. Rest of Europe Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 63. Rest of Europe Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 64. Asia-Pacific Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 65. Asia-Pacific Biological Indicators Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 66. Asia-Pacific Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 67. Asia-Pacific Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 68. Asia-Pacific Sterility Indicators Market, by Country, 2021-2031 ($Million)
Table 69. China Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 70. China Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 71. China Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 72. Japan Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 73. Japan Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 74. Japan Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 75. India Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 76. India Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 77. India Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 78. Australia Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 79. Australia Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 80. Australia Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 81. South Korea Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 82. South Korea Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 83. South Korea Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 84. Rest of Asia-Pacific Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 85. Rest of Asia-Pacific Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 86. Rest of Asia-Pacific Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 87. LAMEA Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 88. LAMEA Biological Indicators Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 89. LAMEA Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 90. LAMEA Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 91. LAMEA Sterility Indicators Market, by Country, 2021-2031 ($Million)
Table 92. Brazil Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 93. Brazil Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 94. Brazil Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 95. Saudi Arabia Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 96. Saudi Arabia Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 97. Saudi Arabia Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 98. South Africa Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 99. South Africa Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 100. South Africa Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 101. Rest of LAMEA Sterility Indicators Market, by Type, 2021-2031 ($Million)
Table 102. Rest of LAMEA Sterility Indicators Market, by Sterilization Process, 2021-2031 ($Million)
Table 103. Rest of LAMEA Sterility Indicators Market, by End-user, 2021-2031 ($Million)
Table 104. 3M: Company Snapshot
Table 105. 3M: Operating Segments
Table 106. 3M: Product Portfolio
Table 107. 3M: Net Sales
Table 108. 3M: Key Strategies
Table 109. Anderson Products, Inc.: Company Snapshot
Table 110. Anderson Products, Inc.: Operating Segments
Table 111. Anderson Products, Inc.: Product Portfolio
Table 112. Anderson Products, Inc.: Net Sales
Table 113. Anderson Products, Inc.: Key Strategies
Table 114. Fortive Corporation: Company Snapshot
Table 115. Fortive Corporation: Operating Segments
Table 116. Fortive Corporation: Product Portfolio
Table 117. Fortive Corporation: Net Sales
Table 118. Fortive Corporation: Key Strategies
Table 119. Cardinal Health Inc.: Company Snapshot
Table 120. Cardinal Health Inc.: Operating Segments
Table 121. Cardinal Health Inc.: Product Portfolio
Table 122. Cardinal Health Inc.: Net Sales
Table 123. Cardinal Health Inc.: Key Strategies
Table 124. Crosstex International, Inc.: Company Snapshot
Table 125. Crosstex International, Inc.: Operating Segments
Table 126. Crosstex International, Inc.: Product Portfolio
Table 127. Crosstex International, Inc.: Net Sales
Table 128. Crosstex International, Inc.: Key Strategies
Table 129. Getinge Ab: Company Snapshot
Table 130. Getinge Ab: Operating Segments
Table 131. Getinge Ab: Product Portfolio
Table 132. Getinge Ab: Net Sales
Table 133. Getinge Ab: Key Strategies
Table 134. Gke GmbH: Company Snapshot
Table 135. Gke GmbH: Operating Segments
Table 136. Gke GmbH: Product Portfolio
Table 137. Gke GmbH: Net Sales
Table 138. Gke GmbH: Key Strategies
Table 139. Hu Friedy Mfg. Co. LLC: Company Snapshot
Table 140. Hu Friedy Mfg. Co. LLC: Operating Segments
Table 141. Hu Friedy Mfg. Co. LLC: Product Portfolio
Table 142. Hu Friedy Mfg. Co. LLC: Net Sales
Table 143. Hu Friedy Mfg. Co. LLC: Key Strategies
Table 144. Matachana Group: Company Snapshot
Table 145. Matachana Group: Operating Segments
Table 146. Matachana Group: Product Portfolio
Table 147. Matachana Group: Net Sales
Table 148. Matachana Group: Key Strategies
Table 149. Mesa Labs, Inc.: Company Snapshot
Table 150. Mesa Labs, Inc.: Operating Segments
Table 151. Mesa Labs, Inc.: Product Portfolio
Table 152. Mesa Labs, Inc.: Net Sales
Table 153. Mesa Labs, Inc.: Key Strategies
Table 154. Mmm Group: Company Snapshot
Table 155. Mmm Group: Operating Segments
Table 156. Mmm Group: Product Portfolio
Table 157. Mmm Group: Net Sales
Table 158. Mmm Group: Key Strategies
Table 159. Nelson Laboratories, LLC: Company Snapshot
Table 160. Nelson Laboratories, LLC: Operating Segments
Table 161. Nelson Laboratories, LLC: Product Portfolio
Table 162. Nelson Laboratories, LLC: Net Sales
Table 163. Nelson Laboratories, LLC: Key Strategies
Table 164. Noxilizer Inc.: Company Snapshot
Table 165. Noxilizer Inc.: Operating Segments
Table 166. Noxilizer Inc.: Product Portfolio
Table 167. Noxilizer Inc.: Net Sales
Table 168. Noxilizer Inc.: Key Strategies
Table 169. Propper Manufacturing Co. Inc.: Company Snapshot
Table 170. Propper Manufacturing Co. Inc.: Operating Segments
Table 171. Propper Manufacturing Co. Inc.: Product Portfolio
Table 172. Propper Manufacturing Co. Inc.: Net Sales
Table 173. Propper Manufacturing Co. Inc.: Key Strategies
Table 174. Sigma Aldrich: Company Snapshot
Table 175. Sigma Aldrich: Operating Segments
Table 176. Sigma Aldrich: Product Portfolio
Table 177. Sigma Aldrich: Net Sales
Table 178. Sigma Aldrich: Key Strategies
Table 179. Steris PLC: Company Snapshot
Table 180. Steris PLC: Operating Segments
Table 181. Steris PLC: Product Portfolio
Table 182. Steris PLC: Net Sales
Table 183. Steris PLC: Key Strategies
Table 184. Stryker Corporation: Company Snapshot
Table 185. Stryker Corporation: Operating Segments
Table 186. Stryker Corporation: Product Portfolio
Table 187. Stryker Corporation: Net Sales
Table 188. Stryker Corporation: Key Strategies

List of Figures
Figure 1. Sterility Indicators Market Segmentation
Figure 2. Sterility Indicators Market, 2021-2031
Figure 3. Sterility Indicators Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Sterility Indicators Mark.:Drivers, Restraints and Opportunities
Figure 12. Sterility Indicators Market, By Type, 2021(%)
Figure 13. Comparative Share Analysis of Biological Indicators Sterility Indicators Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Chemical Indicators Sterility Indicators Market, 2021-2031(%)
Figure 15. Sterility Indicators Market, By Sterilization Process, 2021(%)
Figure 16. Comparative Share Analysis of Steam Sterility Indicators Market, 2021-2031(%)
Figure 17. Comparative Share Analysis of Ethylene Oxide Sterility Indicators Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Dry Heat Sterility Indicators Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Others Sterility Indicators Market, 2021-2031(%)
Figure 20. Sterility Indicators Market, By End-user, 2021(%)
Figure 21. Comparative Share Analysis of Hospitals Sterility Indicators Market, 2021-2031(%)
Figure 22. Comparative Share Analysis of Pharmaceutical Companies and Medical Device Companies Sterility Indicators Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Clinical Laboratories and Research Centers Sterility Indicators Market, 2021-2031(%)
Figure 24. Sterility Indicators Market by Region, 2021
Figure 25. U.S. Sterility Indicators Market, 2021-2031($Million)
Figure 26. Canada Sterility Indicators Market, 2021-2031($Million)
Figure 27. Mexico Sterility Indicators Market, 2021-2031($Million)
Figure 28. Germany Sterility Indicators Market, 2021-2031($Million)
Figure 29. France Sterility Indicators Market, 2021-2031($Million)
Figure 30. Uk Sterility Indicators Market, 2021-2031($Million)
Figure 31. Italy Sterility Indicators Market, 2021-2031($Million)
Figure 32. Spain Sterility Indicators Market, 2021-2031($Million)
Figure 33. Rest of Europe Sterility Indicators Market, 2021-2031($Million)
Figure 34. China Sterility Indicators Market, 2021-2031($Million)
Figure 35. Japan Sterility Indicators Market, 2021-2031($Million)
Figure 36. India Sterility Indicators Market, 2021-2031($Million)
Figure 37. Australia Sterility Indicators Market, 2021-2031($Million)
Figure 38. South Korea Sterility Indicators Market, 2021-2031($Million)
Figure 39. Rest of Asia-Pacific Sterility Indicators Market, 2021-2031($Million)
Figure 40. Brazil Sterility Indicators Market, 2021-2031($Million)
Figure 41. Saudi Arabia Sterility Indicators Market, 2021-2031($Million)
Figure 42. South Africa Sterility Indicators Market, 2021-2031($Million)
Figure 43. Rest of LAMEA Sterility Indicators Market, 2021-2031($Million)
Figure 44. Top Winning Strategies, by Year
Figure 45. Top Winning Strategies, by Development
Figure 46. Top Winning Strategies, by Company
Figure 47. Product Mapping of Top 10 Players
Figure 48. Competitive Dashboard
Figure 49. Competitive Heatmap of Top 10 Key Players
Figure 50. 3.: Net Sales, ($Million)
Figure 51. Anderson Products, Inc.: Net Sales, ($Million)
Figure 52. Fortive Corporatio.: Net Sales, ($Million)
Figure 53. Cardinal Health Inc.: Net Sales, ($Million)
Figure 54. Crosstex International, In.: Net Sales, ($Million)
Figure 55. Getinge A.: Net Sales, ($Million)
Figure 56. Gke Gmb.: Net Sales, ($Million)
Figure 57. Hu Friedy Mfg. Co. LL.: Net Sales, ($Million)
Figure 58. Matachana Grou.: Net Sales, ($Million)
Figure 59. Mesa Labs, Inc.: Net Sales, ($Million)
Figure 60. Mmm Grou.: Net Sales, ($Million)
Figure 61. Nelson Laboratories, LL.: Net Sales, ($Million)
Figure 62. Noxilizer In.: Net Sales, ($Million)
Figure 63. Propper Manufacturing Co. Inc.: Net Sales, ($Million)
Figure 64. Sigma Aldric.: Net Sales, ($Million)
Figure 65. Steris pl.: Net Sales, ($Million)
Figure 66. Stryker Corporatio.: Net Sales, ($Million)

Executive Summary

According to the report, “Sterility Indicator Market," the sterility indicators market size was valued at $879.28 million in 2021, and is estimated to reach $2,599.3 million by 2031, growing at a CAGR of 11.5% from 2022 to 2031. Sterility indicators are used to show or describe how effectively a sterilization process is working. The process of sterilization involves eliminating all living things as well as other foreign or biological agents including bacteria, viruses, fungi, prions, spore forms, and other creatures in a particular area or site. Sterilization techniques include, the use of chemicals, heat, high pressure, radiation, filtration, and others. Sterilization techniques must be checked using biological, mechanical, and chemical sterility markers. Sterility indicators, such as biological, mechanical, and chemical sterility indicators, must be used to monitor sterilization processes.

Factors that drive the growth of the sterility indicators market size include, rise in the number of surgical procedures, rise in the number of product launch, and rise in adoption of different key strategies such as collaboration, acquisition, agreement, and others. In addition, the need for various sterilizing procedures in the biotechnology and pharmaceutical industries, and increase in number of sterility indicators industry is anticipated to be driven by R&D activities. To eradicate all microbial life and prevent contamination, pharmaceutical articles and packing equipment must be sterilized. Due to its efficiency, stem sterilization is gaining a lot of traction. Sterility indicators are used to show or describe how effectively a sterilization process is working, which boosts the sterility indicators market analysis.

In addition, rise in the number of surgical procedures, such as orthopedic surgery, cardiac surgery, and cancer surgeries fuels the need of sterilization procedures in hospitals to sterile surgical instruments and devices, which is further anticipated to fuel the demand for sterility indicators to check effectiveness of sterilization. Thus, driving the growth of the sterility indicators market trends. For instance, according to Canadian Joint Replacement Registry (CJRR), in Canada, the knee and hip replacement surgery is the second most common surgery as per the report shared by Canadian Joint Replacement Registry (CJRR). Approximately more than 75,000 knee replacement and 63,000 hip replacement surgeries were performed in the Canada from 2019 to 2020. This report also states 2.4% increase in the hip replacement surgery from 2019 to 2020. In addition, it is well known that infections picked up in hospitals can make previously hospitalized patients worse off. The use of hospital sterile processing has increased globally. Thus, increased sterilization procedures are anticipated to have a favorable effect on market expansion.

On the basis of type, the sterility indicators market share is segmented into chemical indicators and biological indicators. On the basis of biological indicators bifurcated into self-contained vials, spore strips, and others. The chemical indicators segment dominated the market in 2021, and is expected to continue this trend during the sterility indicators market forecast period, owing to wide use of chemical indicators in steam sterilization process and ethylene oxide sterilization process and rise the number of sterilization process.

On the basis of sterilization process, the market is classified into steam, ethylene oxide, dry heat, and others. The steam segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in the number of steam sterilization procedures in hospitals, biotechnology and pharmaceutical companies.

On the basis of end user, the market is divided into hospitals, pharmaceutical companies and medical device companies, and clinical laboratories/research centers. The pharmaceutical companies and medical device companies segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing rise in the number of pharmaceutical companies and medical device companies and increase in the demand for medicines and medical devices.

North America accounted for a majority of the global sterility indicators market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to increase in the number of root canal procedures, rise in the number of sterility indicators industry who manufactures sterility indicators, and developed healthcare infrastructure in North America. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in the geriatric populations, rise in the awareness regarding usage of sterile products and devices, and rise in the number of chronic diseases.

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global sterility indicators market. The, rise in the awareness about sterile products and increase in the usage of sterile medical equipment surge the demand for sterility indicators boost the growth of the market.

On the other hand, post pandemic impact of COVID-19 on the sterility indicators market is positive owing to rise in the number of surgical procedures after pandemic, which got cancelled or postponed in the pandemic period. Increase in the number of surgical procedures cause rise in demand for sterilization procedures, which fuels the demand for sterility indicators to check sterility of surgical instruments. Thus, fuelling the market growth.

Key Findings of the Study

  • By type, the chemical indicators segment was the highest contributor to the market in 2021.
  • By sterilization process, the steam segment was the highest contributor to the market in 2021.
  • By end user, the pharmaceutical companies and medical device companies segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • 3M
  • Anderson Products, Inc.
  • Fortive Corporation
  • Cardinal Health Inc.
  • Crosstex International, Inc
  • Getinge AB
  • gke GmbH
  • Hu Friedy Mfg. Co., LLC
  • Matachana Group
  • Mesa Labs, Inc.
  • MMM GROUP
  • Nelson Laboratories, LLC
  • NOXILIZER INC
  • Propper Manufacturing Co., Inc.
  • Sigma Aldrich
  • STERIS plc
  • STRYKER CORPORATION

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...